參考資料
- ^ World Health Organization. International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 116 (PDF). WHO Drug Information. 2016, 30 (4) [2024-01-23]. （原始內容存檔 (PDF)於2020-08-07）.
- ^ Izhak L, Cullen DE, Elgawly M, Luistro L, Johnson S, Bald J, Sasser AK, Balasubramanian S. Potent antitumor activity of duvortuxizumab, a CD19 x CD3 DART® molecule, in lymphoma models.. Cancer Research. July 2017. doi:10.1158/1538-7445.AM2017-3636.
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Duvortuxizumab （頁面存檔備份，存於互聯網檔案館）, American Medical Association.
